India’s markets may be nearing the end of a 14-month consolidation cycle, with JM Financial’s Ankur Jhaveri predicting stronger earnings in FY27 and broader market participation ahead. Speaking at India Xchange 2025, he highlights opportunities in autos, data centres, EMS, healthcare, value retail and BFSI, while noting improving consumption trends and rising investor optimism.Read More

Indian stock markets rallied strongly on Wednesday, with both Sensex and Nifty recovering from early dips. A surge in foreign investment and a comeback by key IT companies bolstered investor confidence. Infosys spearheaded the gains, anticipating its substantial share buyback program commencing Thursday. This positive momentum signals a strengthening market sentiment.Read More

Microcap stocks with strong mutual fund ownership are surging in FY26, with 13 names up 70–150% and five already delivering multibagger returns.Read More

Infosys is set to launch its Rs 18,000-crore share buyback on November 20, closing on November 26. The buyback allows the IT giant to repurchase up to 10 crore shares at Rs 1,800 each via the tender offer route. Shareholders as of the record date, November 14, are eligible. Kotak Mahindra Capital manages the issue,...Read More

US equity markets are experiencing a long-overdue correction, impacting global flows into Asia. While India’s fundamentals remain strong, foreign investor sentiment is shifting. Market expert Rahul Arora advises caution on consumer staples, favoring discretionary names and highlighting banking and financials as key investment opportunities.Read More

Three of India’s newest stock market entrants hit their first real stretch of turbulence on Wednesday, as volatile swings, brisk profit-taking and an unusual auction-triggering short squeeze tested investor conviction. Analysts say the corrective moves reflect a shift from debut euphoria to fundamentals, as investors recalibrate near-term risks and reassess positioning after steep post-listing rallies.Read More

Capillary Technologies India is set to finalise share allotment for its ₹877.5 crore IPO today. Applicants can view their allotment status on the BSE website or the registrar MUFG Intime India’s portal once the process is completed. The company’s shares are slated to list on November 21.Read More

Sudeep Pharma’s Rs 895-crore IPO is set to open on November 21, comprising a Rs 95-crore fresh issue and an Rs 800-crore OFS. The price band for the offer is set at Rs 563–593, with 50% of shares reserved for QIBs, 15% for NIIs and 35% for retail investors. With a GMP hovering around 16%...Read More

Public sector banks are rallying, sparking debate on their valuations compared to private lenders. Rahul Arora sees opportunities, especially in SBI and Bank of Baroda. He notes a significant valuation gap remains, suggesting further upside potential for PSU banks. Private banks face growth limitations due to large balance sheets. Global fund flows could favor banks...Read More

Ambit has issued a scathing SELL call on Swiggy, warning its Rs 10,000-crore fundraising plan could worsen losses in the fiercely competitive quick-commerce market. The brokerage says Instamart is lagging Blinkit in scale and efficiency, the market’s growth potential is capped, and Swiggy may need aggressive spending just to hold its ground, limiting long-term profitability.Read More